Savastano, Clementina, and Fortuna Lombardi. “Response to Lapatinib-Capecitabine Combination in a Young Patient With Recurrent HER2-Positive Breast Cancer Refractory to Two Lines of Therapy With Anti-HER2 Drugs: Risposta Alla Combinazione Lapatinib-Capecitabina in Giovane Paziente Con Recidiva Di Carcinoma Della Mammella HER2-Positivo Refrattario a Due Linee Di Terapia Con Farmaci Anti-HER2”. AboutOpen 4, no. 1 (October 12, 2018): 162–165. Accessed November 23, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/135.